Yu Chieh Su | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Yu Chieh Su | Cancer Biology | Best Researcher Award 

Director, Division of Hematology and Oncology | E-DA Hospital | Taiwan

Dr. Yu-Chieh Su’s research focuses on molecular and translational oncology, emphasizing the mechanisms of liver cancer, head and neck cancer, leukemia, and lymphoma. His work investigates tumor biology, resistance pathways, and biomarker discovery to enhance diagnostic accuracy and therapeutic precision. He integrates molecular profiling with immuno-oncology to design targeted therapies that improve patient outcomes. A leader in applying big-data analytics and electronic medical records to oncology, Dr. Su develops predictive models and personalized treatment frameworks using genomic and clinical data integration. His multidisciplinary research extends into artificial intelligence–driven cancer prognosis, genetic biomarker validation, and the study of metabolic influences such as obesity on cancer progression. Through his leadership in national and institutional research initiatives, he has strengthened Taiwan’s position in precision oncology and data-guided cancer care. His contributions have been widely recognized, as reflected in his impressive research metrics, including 4558 total citations, an h-index of 39, and an i10-index of 102 (Google Scholar), with 3,297 citations, an h-index of162, and an i31-index of 69 (Scopus). These achievements demonstrate Dr. Su’s enduring impact on cancer biology, translational research, and the advancement of evidence-based oncology worldwide.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Su, Y.-C., et al. Prognostic significance of neutrophil-to-lymphocyte ratio in hepatocellular carcinoma. Frontiers in Oncology. — Cited by 128 articles.

Su, Y.-C., et al. Integrative genomic analysis reveals biomarkers for head and neck cancer. BMC Cancer. — Cited by 94 articles.

Su, Y.-C., et al. Clinical outcomes of hematologic malignancies under novel immunotherapy protocols. Medicine (Baltimore). — Cited by 87 articles.

Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award 

Doctorate | ICOA | France

Dr. Rouba Nasreddine is an accomplished Lebanese-French scientist and Associate Professor at the University of Orléans, France, specializing in analytical chemistry and environmental analysis. She is a member of the Analytical Strategies, Affinities and Bioactives (SAAB) research team at the Institute of Organic and Analytical Chemistry (ICOA), where her work bridges analytical innovation and environmental sustainability through advanced detection methods for bioaerosols and volatile organic compounds. Her research contributions extend across chromatography, spectroscopy, and microscale thermophoresis, with a focus on enzyme dynamics and molecular affinities in complex environments. She has published 19 scientific documents, cited 327 times across 283 sources, and holds an h-index of 11, reflecting her growing impact in the field. Dr. Nasreddine’s interdisciplinary collaborations and teaching at the University Institute of Technology of Orléans continue to inspire innovation in analytical science and sustainable chemistry.

Profile: Scopus | ORCID

Featured Publications

Nasreddine, R., et al. (2025). Molecules, 30, 4008. [Cited by 12 articles]

Kharrat, O., et al. (2025). PNAS, 122, e2415524122. [Cited by 24 articles]

Kharrat, O., et al. (2025). J. Biol. Chem., 301, 110587. [Cited by 16 articles]

Chartier, S., et al. (2025). Analytica Chimica Acta, 1360, 344145. [Cited by 8 articles]

Quinty, V., et al. (2023). Food Bioscience, 55, 103069. [Cited by 20 articles]